1. Home
  2. BEAM vs PTRN Comparison

BEAM vs PTRN Comparison

Compare BEAM & PTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$31.65

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

PTRN

Pattern Group Inc.

N/A

Current Price

$14.21

Market Cap

2.4B

ML Signal

N/A

Company Overview

Basic Information
Metric
BEAM
PTRN
Founded
2017
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Catalog/Specialty Distribution
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.4B
IPO Year
2020
2025

Fundamental Metrics

Financial Performance
Metric
BEAM
PTRN
Price
$31.65
$14.21
Analyst Decision
Buy
Strong Buy
Analyst Count
14
10
Target Price
$46.00
$19.89
AVG Volume (30 Days)
2.0M
881.6K
Earning Date
02-24-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$55,701,000.00
$2,293,676,000.00
Revenue This Year
N/A
$39.63
Revenue Next Year
$26.52
$24.32
P/E Ratio
N/A
N/A
Revenue Growth
N/A
67.86
52 Week Low
$13.53
$11.21
52 Week High
$36.44
$20.10

Technical Indicators

Market Signals
Indicator
BEAM
PTRN
Relative Strength Index (RSI) 56.44 N/A
Support Level $29.80 N/A
Resistance Level $35.34 N/A
Average True Range (ATR) 2.80 0.00
MACD 0.14 0.00
Stochastic Oscillator 55.79 0.00

Price Performance

Historical Comparison
BEAM
PTRN

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

About PTRN Pattern Group Inc.

Pattern Group Inc is an ecommerce accelerator, uses its technology platform, data science and a team of experts to drive growth for brands. The Company acquires inventory from brand partners to sell to consumers, enabling full control over content, pricing, logistics and customer service. Brand partners that contract with the Company operate in various industries including health and wellness, beauty and personal care, home and lifestyle, pet, sports and outdoors and consumer electronics.

Share on Social Networks: